相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement-interleukin-1β loop
Xiaolu Zhu et al.
HAEMATOLOGICA (2019)
Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus
Y. Chu et al.
LUPUS (2019)
Immune Thrombocytopenia
Nichola Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
Abderrahim Khelif et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert et al.
BLOOD ADVANCES (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD ADVANCES (2019)
Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-B/SMAD pathway in patients with immune thrombocytopenia
Yun He et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia
Q. Feng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
All-Trans Retinoic Acid Modulates TLR4/NF-κB Signaling Pathway Targeting TNF-α and Nitric Oxide Synthase 2 Expression in Colonic Mucosa during Ulcerative Colitis and Colitis Associated Cancer
Hayet Rafa et al.
MEDIATORS OF INFLAMMATION (2017)
Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1/Jagged-1 Signaling Pathway
Lin-lin Xu et al.
STEM CELLS AND DEVELOPMENT (2017)
Is oral all-trans retinoic acid plus danazol a refinement of second-line therapy for primary immune thrombocytopenia in adults?
Simon Panzer et al.
LANCET HAEMATOLOGY (2017)
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
Fei-Er Feng et al.
LANCET HAEMATOLOGY (2017)
A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy
Zhangyuan Kong et al.
BLOOD (2017)
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
Yu Wei et al.
BLOOD (2016)
Efficacy of immunomodulatory therapy with all-trans retinoid acid in adult patients with chronic immune thrombocytopenia
Lan Dai et al.
THROMBOSIS RESEARCH (2016)
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP
Hai Zhou et al.
BLOOD (2015)
Fatigue in immune thrombocytopenia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
David Gomez-Almaguer et al.
BLOOD (2014)
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Guillaume Moulis et al.
BLOOD (2014)
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Sif Gudbrandsdottir et al.
BLOOD (2013)
Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
Patrick F. Fogarty et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Retinoic Acid Attenuates Rheumatoid Inflammation in Mice
Seung-Ki Kwok et al.
JOURNAL OF IMMUNOLOGY (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Successful Treatment With Retinoids in Patients With Lupus Nephritis
Koji Kinoshita et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials
James N. George et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences
Susan D. Mathias et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation
Susan D. Mathias et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2007)
Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis
Yuji Nozaki et al.
CLINICAL IMMUNOLOGY (2006)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
